Any current/future capex/capital investment/strategic investment?

LTIMindtree continues to evaluate multiple M&A candidates on a daily basis as part of their strategic investment approach. There is no immediate change planned in their capital allocation or payout policy; investments are considered based on profitability, not just cash balances. The company aims to generate higher returns and cash flow before increasing cash payouts. They are actively investing in business growth, including rehiring and building bench strength to prepare for deal ramp-ups. Investments include training over 10,000 employees on Generative AI to stay competitive in AI-driven opp

Future growth expectations in sales/revenue/volumes?

Growth outlook for Q4 expected to be similar to Q3, reflecting caution in macroeconomic environment and client decision-making delays. Strong order inflow ($1.5 billion in Q3, 21% YoY growth) and healthy pipeline (~$4.6 billion, 30% increase YoY) signal medium-term growth potential. Large deals ramp-ups ongoing but slower than initially expected; some deals in final stages facing delayed decisions. Growth to be broad-based across industry verticals and geographies, not reliant on any single vertical. Discretionary spend remains subdued, impacting near-term growth; expected gradual reco

Future growth expectations in earnings/operating earnings/profits/EPS?

Growth outlook for H2 FY24 has been revised down materially due to macroeconomic uncertainties and discretionary spend reduction. Large deals with transitions require ramp-up time; decision-making delays have impacted revenue realization. Utilization was higher than expected in previous quarters; plans to reduce utilization to build sufficient bench for upcoming deals, preparing for growth. Strong order inflow and healthy $4.6 billion deal pipeline support medium-term growth prospects. Margin improvement program continues, but margin expansion targets (17%-18%) have been deferred by a few quar

Current/ Expected Orderbook/ Pending Orders?

LTIMindtree reported a strong order inflow of USD 1.5 billion in Q3 FY24, marking a 21% year-on-year growth despite a cautionary macro environment. The 9-month FY24 order inflow stands at USD 4.2 billion, showing 19% year-on-year growth. The overall deal pipeline is approximately USD 4.6 billion, representing a 30% increase compared to the same time last year. The company is actively participating in over 30 "advice deals," indicating strong positioning in large deal pipelines. Many deals in the pipeline are in their final stages of closure, although decision-making delays have been observed.

Any current/future new fundraising through debt or equity?

There is no mention of any current or planned new fundraising through debt or equity in the provided transcript. The company has a strong cash balance of around ₹10,000 crores (USD 1.216 billion) as of Q3 FY24. They continue to evaluate multiple candidates for M&A opportunities daily but have not indicated any immediate fundraising related to these. The payout policy is based on profitability rather than cash balance, and there will be no changes in the short run regarding payouts. Overall, the company appears focused on utilizing existing cash reserves and refrains from indicating any new fun

IN US

Sale is live|00:00:00left today

LTM LtdQ4 FY25IT - Software

LTM Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,845P/E: 23.4Market Cap: ₹1.3L CrSector: IT - Software

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Growth outlook for Q4 expected to be similar to Q3, reflecting caution in macroeconomic environment and client decision-making delays.
→Strong order inflow ($1.5 billion in Q3, 21% YoY growth) and healthy pipeline (~$4.6 billion, 30% increase YoY) signal medium-term growth potential.
→Large deals ramp-ups ongoing but slower than initially expected; some deals in final stages facing delayed decisions.
→Growth to be broad-based across industry verticals and geographies, not reliant on any single vertical.
→Discretionary spend remains subdued, impacting near-term growth; expected gradual recovery with some return of furloughs in Q4 and beyond.
→Investments continue in business and capabilities (e.g., AI training for 10,000 employees), with margin targets deferred to prioritize growth readiness.
→Despite uncertainties, pipeline strength and large deal wins provide optimism for improved execution and growth in FY25.

Margin guidance

Category 2

→Growth outlook for H2 FY24 has been revised down materially due to macroeconomic uncertainties and discretionary spend reduction.
→Large deals with transitions require ramp-up time; decision-making delays have impacted revenue realization.
→Utilization was higher than expected in previous quarters; plans to reduce utilization to build sufficient bench for upcoming deals, preparing for growth.
→Strong order inflow and healthy $4.6 billion deal pipeline support medium-term growth prospects.
→Margin improvement program continues, but margin expansion targets (17%-18%) have been deferred by a few quarters due to reinvestments in growth and cautious market conditions.
→Operating margins expected to improve gradually; furlough impacts on margins will ease gradually through Q4 FY24.
→Earnings and EPS growth expected to moderate near term but positioned for a medium-term recovery as large deals materialize and discretionary spending improves in FY25.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no mention of any current or planned new fundraising through debt or equity in the provided transcript.
→The company has a strong cash balance of around ₹10,000 crores (USD 1.216 billion) as of Q3 FY24.
→They continue to evaluate multiple candidates for M&A opportunities daily but have not indicated any immediate fundraising related to these.
→The payout policy is based on profitability rather than cash balance, and there will be no changes in the short run regarding payouts.
→Overall, the company appears focused on utilizing existing cash reserves and refrains from indicating any new fundraising through debt or equity at this time.

Order book

Yes

→LTIMindtree reported a strong order inflow of USD 1.5 billion in Q3 FY24, marking a 21% year-on-year growth despite a cautionary macro environment.
→The 9-month FY24 order inflow stands at USD 4.2 billion, showing 19% year-on-year growth.
→The overall deal pipeline is approximately USD 4.6 billion, representing a 30% increase compared to the same time last year.
→The company is actively participating in over 30 "advice deals," indicating strong positioning in large deal pipelines.
→Many deals in the pipeline are in their final stages of closure, although decision-making delays have been observed.
→The strong order book and healthy pipeline support the company's medium-term growth outlook.

Capex plans

Yes

→LTIMindtree continues to evaluate multiple M&A candidates on a daily basis as part of their strategic investment approach.
→There is no immediate change planned in their capital allocation or payout policy; investments are considered based on profitability, not just cash balances.
→The company aims to generate higher returns and cash flow before increasing cash payouts.
→They are actively investing in business growth, including rehiring and building bench strength to prepare for deal ramp-ups.
→Investments include training over 10,000 employees on Generative AI to stay competitive in AI-driven opportunities.
→Margin improvement programs are ongoing but deferred partly to allow reinvestment in SG&A and bench, supporting future growth.
→No explicit capex numbers are mentioned; the focus is on strategic investments, integration efficiencies, and sustaining growth momentum.

How does LTM Ltd rank vs peers in IT - Software?

Pro feature

1LTM Ltd

Rev 3Mar 2

See full IT - Software sector rankings

Want more stocks like LTM Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio